[{"symbol": "PFE", "publishedDate": "2019-06-30 12:15:00", "title": "Pfizer's About to Enter a Sales Slump -- Here's Why You Should Like the Stock Anyway", "image": "https://cdn.snapi.dev/images/v1/l/i/pfz.jpg", "site": "The Motley Fool", "text": "Don't ignore the fallout from Lyrica's loss of patent exclusivity. But do look beyond it.", "url": "https://www.fool.com/investing/2019/06/30/pfizers-about-to-enter-a-sales-slump-heres-why-you.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-29 08:48:02", "title": "Pfizer\u2019s Duchenne Muscular Dystrophy Pain Could Make Sarepta the DMD King", "image": "https://cdn.snapi.dev/images/v1/b/p/15pha.jpg", "site": "24/7 Wall Street", "text": "Pfizer Inc. (NYSE: PFE) has released initial clinical data from its Phase 1b gene therapy study for Duchenne muscular dystrophy (DMD).", "url": "https://247wallst.com/healthcare-business/2019/06/29/pfizers-duchenne-muscular-dystrophy-pain-could-make-sarepta-the-dmd-king/"}, {"symbol": "PFE", "publishedDate": "2019-06-28 18:07:38", "title": "These Are The 5 Worst Dow Jones Stocks In The First Half Of 2019", "image": "https://cdn.snapi.dev/images/v1/d/o/dowdow2.jpg", "site": "Investors Business Daily", "text": "Health-related stocks were among the worst-performing Dow Jones stocks during the first half of 2019, led by Walgreens Boots Alliance.", "url": "https://www.investors.com/news/dow-jones-stocks-walgreens-3m-unitedhealth-pfizer-verizon-worst-in-1h-2019/"}, {"symbol": "PFE", "publishedDate": "2019-06-28 10:55:43", "title": "Former FDA Commissioner has joined the board of directors at Pfizer Inc.", "image": "https://cdn.snapi.dev/images/v1/d/j/drugs1.jpg", "site": "Market Watch", "text": "Former U.S. Food and Drug Administration Commissioner Scott Gottlieb has joined the board of directors at Pfizer Inc.", "url": "https://www.marketwatch.com/story/former-fda-commissioner-scott-gottlieb-joins-pfizers-board-of-directors-2019-06-28"}, {"symbol": "PFE", "publishedDate": "2019-06-28 07:49:12", "title": "Pfizer says FDA has approved its oncology biosimilar Zirabev to treat 5 types of cancer", "image": "https://cdn.snapi.dev/images/v1/e/t-2/drugs46.jpg", "site": "Market Watch", "text": "Pfizer Inc. PFE, +1.02% said Friday the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer.", "url": "https://www.marketwatch.com/story/pfizer-says-fda-has-approved-its-oncology-biosimilar-zirabev-to-treat-5-types-of-cancer-2019-06-28"}, {"symbol": "PFE", "publishedDate": "2019-06-27 17:17:59", "title": "Pfizer names former FDA chief Scott Gottlieb to its board", "image": "https://cdn.snapi.dev/images/v1/d/r/m02d20190627t2i1402189472rlynxnpef5q21jw640.jpg", "site": "Reuters", "text": "Pfizer Inc  said on Thursday it has named former U.S. Food and Drug Administration Commissioner Scott Gottlieb to its board of directors, effective immediately.", "url": "https://www.reuters.com/article/us-pfizer-board/pfizer-names-former-fda-chief-scott-gottlieb-to-its-board-idUSKCN1TS36L"}, {"symbol": "PFE", "publishedDate": "2019-06-27 16:50:54", "title": "Former FDA Chief Scott Gottlieb joins Pfizer's board", "image": "https://cdn.snapi.dev/images/v1/o/g/former-fda-chief-scott-gottlieb-joins-pfizers-board.jpg", "site": "CNBC Television", "text": "CNBC's Seema Mody reports on news that Pfiezer has named former FDA Chief Scott Gottlieb to its board.", "url": "https://www.youtube.com/watch?v=Onie7VJnX2U"}, {"symbol": "PFE", "publishedDate": "2019-06-27 16:26:00", "title": "Former FDA Commissioner Scott Gottlieb joins Pfizer's board of directors", "image": "https://cdn.snapi.dev/images/v1/6/3/105925105-1558449878026nup-187141-0485cr.jpg", "site": "CNBC", "text": "Scott Gottlieb, who stepped down as Food and Drug Administration Commissioner in April, will join Pfizer's board of directors, the company announced Thursday.", "url": "https://www.cnbc.com/2019/06/27/former-fda-commissioner-scott-gottlieb-joins-pfizers-board.html"}, {"symbol": "PFE", "publishedDate": "2019-06-27 11:08:01", "title": "The 7 Top Small-Cap Stocks Of 2019", "image": "https://cdn.snapi.dev/images/v1/e/t/etf33-27.jpg", "site": "InvestorPlace", "text": "Small-cap stocks have under-performed their large cap peers in 2019, but these 7 small-cap stocks have each more than tripled this year.", "url": "https://investorplace.com/2019/06/the-7-top-small-cap-stocks-of-2019/"}, {"symbol": "PFE", "publishedDate": "2019-06-27 07:21:00", "title": "UnitedHealth and one other Dow stock could be on the cusp of a comeback", "image": "https://cdn.snapi.dev/images/v1/u/n/unip55.jpg", "site": "CNBC", "text": "As the Dow closes in on records, just four stocks have been shut out of the rally. Some could be on the verge of a major breakout.", "url": "https://www.cnbc.com/2019/06/27/unitedhealth-and-pfizer-could-be-on-the-cusp-of-a-comeback.html"}, {"symbol": "PFE", "publishedDate": "2019-06-25 20:07:00", "title": "3 Dividend Stocks That Could Pay You the Rest of Your Life", "image": "https://cdn.snapi.dev/images/v1/a/s/asset-management24-13.jpg", "site": "The Motley Fool", "text": "This drug company, renewable power generator, and candymaker should provide investors with a steady stream of income in the decades to come.", "url": "https://www.fool.com/investing/2019/06/25/3-dividend-stocks-that-could-pay-you-the-rest-of-y.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-25 17:45:23", "title": "Pfizer (PFE) Flat As Market Sinks: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/q/x/drugs50.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Pfizer (PFE) closed at $43.76, marking no change from the previous day.", "url": "https://www.zacks.com/stock/news/434254/pfizer-pfe-flat-as-market-sinks-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2019-06-25 12:46:38", "title": "3 Healthcare Stocks to Buy With the Market Near All-Time Highs", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcaremsn4-2.jpg", "site": "InvestorPlace", "text": "PFE, JNJ and UNH are three healthcare stocks to buy even up near all-time market highs. Each for its own reasons.", "url": "https://investorplace.com/2019/06/3-healthcare-stocks-to-buy-with-the-market-near-all-time-highs/"}, {"symbol": "PFE", "publishedDate": "2019-06-24 15:33:11", "title": "The 7 Best Acquisitions of 2019", "image": "https://cdn.snapi.dev/images/v1/m/e/mergermsn.jpg", "site": "InvestorPlace", "text": "The $28 billion acquisition is the eighth-largest bank deal of all time. It\u2019s expected to close in the fourth quarter.", "url": "https://investorplace.com/2019/06/the-7-best-acquisitions-of-2019/"}, {"symbol": "PFE", "publishedDate": "2019-06-24 09:43:00", "title": "Read This Before You Buy Any New Cancer Drug Stocks", "image": "https://cdn.snapi.dev/images/v1/d/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5294672flaboratory-technician-pipeting-bloodjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Around $36 billion worth of biopharma acquisitions over the past few years suggests smaller might be better.", "url": "https://www.fool.com/investing/2019/06/24/read-this-before-you-buy-any-new-cancer-drug-stock.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-24 08:33:00", "title": "Pfizer's Talzenna Gets Approval in Europe for Breast Cancer", "image": "https://cdn.snapi.dev/images/v1/0/y/drugs7.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) PARP inhibitor, Talzenna, receives approval in Europe for treating BRCA-mutated locally advanced or metastatic breast cancer.", "url": "https://www.zacks.com/stock/news/433383/pfizers-talzenna-gets-approval-in-europe-for-breast-cancer"}, {"symbol": "PFE", "publishedDate": "2019-06-23 09:00:00", "title": "These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?", "image": "https://cdn.snapi.dev/images/v1/z/q/biotech38-6.jpg", "site": "The Motley Fool", "text": "These stocks were huge winners last week. But can their momentum continue?", "url": "https://www.fool.com/investing/2019/06/23/these-3-biotech-stocks-skyrocketed-last-week-are-t.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-21 14:40:15", "title": "5 Dow Stocks Not Allowing the DJIA a Proper Rally", "image": "https://cdn.snapi.dev/images/v1/e/t/etf7-22.jpg", "site": "24/7 Wall Street", "text": "The markets have been on a wild ride in this year. The seasonal theme of \u201cSell in May and go away\u201d passed and seemingly has turned into \u201cHold your nose and buy in June.", "url": "https://247wallst.com/investing/2019/06/21/5-dow-stocks-not-allowing-the-djia-a-proper-rally/"}, {"symbol": "PFE", "publishedDate": "2019-06-21 11:57:54", "title": "Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA", "image": "https://cdn.snapi.dev/images/v1/y/c/medic-563423-1920-1-2.jpg", "site": "Benzinga", "text": "Pfizer (NYSE:PFE) has received approval from the European Commission for its TALZENNA a breast cancer drug.", "url": "https://www.benzinga.com/news/19/06/13957440/pfizer-receives-european-commission-approval-for-breast-cancer-drug-talzenna"}, {"symbol": "PFE", "publishedDate": "2019-06-20 04:18:09", "title": "GSK offers concessions to address EU concerns over Pfizer deal", "image": "https://cdn.snapi.dev/images/v1/i/k/m02d20190620t2i1399681607rlynxnpef5j0juw640.jpg", "site": "Reuters", "text": "GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer's consumer health business, the European Commission said on Thursday.", "url": "https://www.reuters.com/article/us-pfizer-m-a-gsk-eu/gsk-offers-concessions-to-address-eu-concerns-over-pfizer-deal-idUSKCN1TL0R0"}, {"symbol": "PFE", "publishedDate": "2019-06-19 11:47:14", "title": "Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years", "image": "https://cdn.snapi.dev/images/v1/b/p/drugs4.jpg", "site": "Investors Business Daily", "text": "Dow Jones component Pfizer could become a leader in colon cancer treatment with its looming $11.4 billion acquisition of biotech company Array BioPharma, an analyst said Wednesday.", "url": "https://www.investors.com/news/technology/cancer-treatment-pfizer-buying-biotech-company-array/"}, {"symbol": "PFE", "publishedDate": "2019-06-19 09:06:00", "title": "Big Drugmakers That May Tread the M&A Path After Pfizer", "image": "https://cdn.snapi.dev/images/v1/3/8/383-3.jpg", "site": "Zacks Investment Research", "text": "There has been a flurry of M&A deal announcements this year in the drug industry. Here we discuss three big drug/biotech companies, which may make the next M&A move.", "url": "https://www.zacks.com/stock/news/431504/big-drugmakers-that-may-tread-the-ma-path-after-pfizer"}, {"symbol": "PFE", "publishedDate": "2019-06-19 07:56:15", "title": "3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company", "image": "https://cdn.snapi.dev/images/v1/e/t/etf26-39.jpg", "site": "InvestorPlace", "text": "The stock charts of MKC, FMC and PFE are at major turning points here at the midpoint of the trading week.", "url": "https://investorplace.com/2019/06/3-big-stock-charts-for-wednesday-pfe-mkc-fmc/"}, {"symbol": "PFE", "publishedDate": "2019-06-18 09:51:00", "title": "Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio", "image": "https://cdn.snapi.dev/images/v1/b/a/biotech23.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) offers $48 per share to buy Array BioPharma and strengthen its cancer portfolio.", "url": "https://www.zacks.com/stock/news/431106/pfizer-to-buy-array-biopharma-broaden-cancer-portfolio"}, {"symbol": "PFE", "publishedDate": "2019-06-18 07:57:29", "title": "5 Dividend Leaders To Buy From Merrill Lynch\u2019s Large Cap Defensive Portfolio", "image": "https://cdn.snapi.dev/images/v1/e/t/etf5-24.jpg", "site": "24/7 Wall Street", "text": "With summer starting on Friday, we could be in for a hot three months in more ways than one.", "url": "https://247wallst.com/investing/2019/06/18/5-dividend-leaders-to-buy-from-merrill-lynchs-large-cap-defensive-portfolio/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 18:48:58", "title": "Biotech M&A Boom: 4 trades", "image": "https://cdn.snapi.dev/images/v1/t/f/tfs72.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you 4 trades in Biotech as the deal space heats up in the sector.", "url": "https://www.youtube.com/watch?v=AfpX7f4Uy_Y"}, {"symbol": "PFE", "publishedDate": "2019-06-17 18:36:07", "title": "Fmr. FDA commissioner on biotech", "image": "https://cdn.snapi.dev/images/v1/m/q-5/fmr-fda-commissioner-on-biotech.jpg", "site": "CNBC Television", "text": "Former FDA Commissioner Scott Gottlieb on biotech", "url": "https://www.youtube.com/watch?v=YqJDCmWU2Lg"}, {"symbol": "PFE", "publishedDate": "2019-06-17 17:06:21", "title": "Pfizer strengthens its position in cancer", "image": "https://cdn.snapi.dev/images/v1/u/g/biotech3.jpg", "site": "The Motley Fool", "text": "Acquisitions made headlines, with Pfizer buying Array BioPharma.", "url": "https://www.fool.com/investing/2019/06/17/what-happened-in-the-stock-market-today.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-17 17:00:00", "title": "Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon", "image": "https://cdn.snapi.dev/images/v1/e/s/esuq7.jpg", "site": "The Motley Fool", "text": "The big drugmaker is spending more than $11 billion for the cancer-drug specialist.", "url": "https://www.fool.com/investing/2019/06/17/why-pfizers-acquisition-of-array-biopharma-wont-pa.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-17 16:05:26", "title": "Five Top Stock Trades for Tuesday June 18", "image": "https://cdn.snapi.dev/images/v1/s/t/stoc99.jpg", "site": "InvestorPlace", "text": "Gilead Sciences, Pfizer, Tesla, Netflx and Facebook are our top stock trades for Tuesday. Here's a look at the charts.", "url": "https://investorplace.com/2019/06/5-top-stock-trades-for-tuesday-fb-nflx-gild-tsla/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 12:11:58", "title": "Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal", "image": "https://cdn.snapi.dev/images/v1/q/i/biotech11.jpg", "site": "InvestorPlace", "text": "Array BioPharma news for Monday concerning a deal with Pfizer (PFE) that will have the two companies coming together has ARRY stock soaring.", "url": "https://investorplace.com/2019/06/array-biopharma-news-boosts-arry-stock/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 11:56:07", "title": "How Much Is Pfizer Overpaying For Array Bio?", "image": "https://cdn.snapi.dev/images/v1/g/o/pf9-3.jpg", "site": "24/7 Wall Street", "text": "Array BioPharma Inc. shares shot up on Monday after the firm announced that it would be acquired by Pfizer Inc. in an all cash transaction.", "url": "https://247wallst.com/healthcare-business/2019/06/17/how-much-is-pfizer-overpaying-for-array-bio/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 11:32:21", "title": "Stock Market News: Array Get Winning Bids on a Big Deal Day", "image": "https://cdn.snapi.dev/images/v1/4/6/biotech17.jpg", "site": "The Motley Fool", "text": "Wall Street was in an optimistic mood on Monday morning.", "url": "https://www.fool.com/investing/2019/06/17/stock-market-news-sothebys-array-get-winning-bids.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-17 10:33:00", "title": "\"Merger Monday\" Returns: Pfizer Buying Array", "image": "https://cdn.snapi.dev/images/v1/o/8/biotech10.jpg", "site": "Zacks Investment Research", "text": "News on two major mergers in their respective industries are taking headlines, along with a fresh regional economic read.", "url": "https://www.zacks.com/stock/news/430565/merger-monday-returns-pfizer-buying-array-t-mobile-sprint-on-ice"}, {"symbol": "PFE", "publishedDate": "2019-06-17 09:58:02", "title": "Pfizer will access Array's approved cancer drugs in $11 billion deal", "image": "https://cdn.snapi.dev/images/v1/y/2/pfizer-will-access-arrays-approved-cancer-drugs-in-11-billion-deal.jpg", "site": "CNBC Television", "text": "Dow component Pfizer is buying Array Biopharma for $48 per share in cash, or $11.4 billion.", "url": "https://www.youtube.com/watch?v=0E2mWA269PQ"}, {"symbol": "PFE", "publishedDate": "2019-06-17 09:49:44", "title": "Pfizer acquires array biopharma in $10.64B deal", "image": "https://cdn.snapi.dev/images/v1/f/p/pfizer-acquires-array-biopharma-in-1064b-deal.jpg", "site": "Yahoo Finance", "text": "Pfizer is buying Array BioPharma in a deal valued at $10.6 billion.", "url": "https://www.youtube.com/watch?v=pW7KVOjEILc"}, {"symbol": "PFE", "publishedDate": "2019-06-17 09:34:37", "title": "How An $11.4 Billion Takeover Will Deepen Pfizer's Efforts In Cancer", "image": "https://cdn.snapi.dev/images/v1/r/b/drugs9.jpg", "site": "Investors Business Daily", "text": "Dow Jones component Pfizer announced Monday an $11.4 billion plan to acquire biotech company Array BioPharma, which is working on cancer treatments.", "url": "https://www.investors.com/news/technology/biotech-company-array-acquired-pfizer-deal-cancer-treatments/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 09:22:00", "title": "Why Array BioPharma Stock Is on Fire Today", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech18-6.jpg", "site": "The Motley Fool", "text": "Pfizer moves to acquire the cancer specialist in a deal valued at $11.4 billion.", "url": "https://www.fool.com/investing/2019/06/17/why-array-biopharma-inc-is-on-fire-today.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-17 08:44:00", "title": "S&P places Pfizer ratings on CreditWatch negative after $11.4 billion Array deal", "image": "https://cdn.snapi.dev/images/v1/g/v/pf9.jpg", "site": "Market Watch", "text": "S&P Global Ratings placed Pfizer Inc.'s ratings on CreditWatch negative on Monday, after the drug company announced that it is acquiring Array BioPharma Inc.", "url": "https://www.marketwatch.com/story/sp-places-pfizer-ratings-on-creditwatch-negative-after-114-billion-array-deal-2019-06-17"}, {"symbol": "PFE", "publishedDate": "2019-06-17 07:55:36", "title": "Pfizer To Buy Array BioPharma For $48/Share", "image": "https://cdn.snapi.dev/images/v1/c/j/medicine-2520463-1920-20.jpg", "site": "Benzinga", "text": "Array BioPharma (NASDAQ: ARRY) shares are trading sharply higher after the company announced it will be acquired by Pfizer (NYSE: PFE) for $48 per share in cash for a total value of around $11.4 billion.", "url": "https://www.benzinga.com/general/biotech/19/06/13928334/pfizer-to-buy-array-biopharma-for-48share"}, {"symbol": "PFE", "publishedDate": "2019-06-17 07:35:22", "title": "Pfizer buys Array Biopharma for $48/share in cash", "image": "https://cdn.snapi.dev/images/v1/p/a/pah82.jpg", "site": "CNBC Television", "text": "Dow component Pfizer is buying Array Biopharma for $48 per share in cash, or $11.4 billion.", "url": "https://www.youtube.com/watch?v=2wDGoXrrMPk"}, {"symbol": "PFE", "publishedDate": "2019-06-17 06:56:59", "title": "Array BioPharma's stock rockets after $11.4 billion buyout deal with Pfizer", "image": "https://cdn.snapi.dev/images/v1/q/k/biotech4.jpg", "site": "Market Watch", "text": "Shares of Array BioPharma Inc. ARRY, +0.58% rocketed 56% toward a record high in premarket trading Monday, after biopharmaceutical company developing cancer treatments agreed to be acquired by Pfizer Inc.", "url": "https://www.marketwatch.com/story/array-biopharmas-stock-rockets-after-114-billion-buyout-deal-with-pfizer-2019-06-17"}, {"symbol": "PFE", "publishedDate": "2019-06-17 06:56:16", "title": "Pfizer to buy Array for $10.64 billion", "image": "https://cdn.snapi.dev/images/v1/4/c/m02d20190617t2i1398681146rlynxnpef5g0nmw640.jpg", "site": "Reuters", "text": "Pfizer Inc said on Monday it had agreed to acquire Array Biopharma Inc for $10.64 billion, which will grant it access to its cancer drugs.", "url": "https://www.reuters.com/article/us-array-biopharma-m-a-pfizer/pfizer-to-buy-array-for-10-64-billion-idUSKCN1TI15T"}, {"symbol": "PFE", "publishedDate": "2019-06-15 08:00:00", "title": "5 Biggest Blockbuster Drugs of the Future", "image": "https://cdn.snapi.dev/images/v1/d/r/drugs50.jpg", "site": "The Motley Fool", "text": "Each of these drugs is forecast to rake in at least $9.5 billion in 2024. Investors looking to profit should pay attention to the pharmaceutical giants that sell them.", "url": "https://www.fool.com/investing/2019/06/15/5-biggest-blockbuster-drugs-of-the-future.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-14 06:25:34", "title": "7 Stocks Not Enjoying the Bull Market and Holding Down the Dow in 2019", "image": "https://cdn.snapi.dev/images/v1/e/t/etf16-38.jpg", "site": "24/7 Wall Street", "text": "It\u2019s been a wild ride in 2019. The seasonal theme of \u201csell in May and go away\u201d passed and seemingly has turned into \u201cHold your nose and buy in June.", "url": "https://247wallst.com/investing/2019/06/14/7-stocks-not-enjoying-the-bull-market-and-holding-down-the-dow-in-2019/"}, {"symbol": "PFE", "publishedDate": "2019-06-13 08:24:00", "title": "Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study", "image": "https://cdn.snapi.dev/images/v1/f/b/drugs33.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) study on JAK inhibitor Xeljanz XR demonstrates the efficacy of the medicine when used as a monotherapy without methotrexate.", "url": "https://www.zacks.com/stock/news/428916/pfizers-pfe-xeljanz-effective-as-monotherapy-in-ra-study"}, {"symbol": "PFE", "publishedDate": "2019-06-12 16:58:48", "title": "6 Large-Cap Stocks Outperforming the Benchmark", "image": "https://cdn.snapi.dev/images/v1/e/t/etf45-15.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-in-One Screener, the following stocks have outperformed the Standard & Poor's 500 Index over the last 12 months.", "url": "https://www.gurufocus.com/news/893322/6-largecap-stocks-outperforming-the-benchmark"}, {"symbol": "PFE", "publishedDate": "2019-06-12 10:36:00", "title": "Top Ranked Income Stocks to Buy for June 12th 2019", "image": "https://cdn.snapi.dev/images/v1/e/t/etf20-24.jpg", "site": "Zacks Investment Research", "text": "Top Ranked Income Stocks to Buy for June 12th", "url": "https://www.zacks.com/commentary/428514/top-ranked-income-stocks-to-buy-for-june-12th"}, {"symbol": "PFE", "publishedDate": "2019-06-12 08:30:17", "title": "Big Pharma Sees a Rising Tide in Short Interest", "image": "https://cdn.snapi.dev/images/v1/1/5/15pha.jpg", "site": "24/7 Wall Street", "text": "Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials.", "url": "https://247wallst.com/healthcare-business/2019/06/12/big-pharma-sees-a-rising-tide-in-short-interest/"}, {"symbol": "PFE", "publishedDate": "2019-06-12 08:28:00", "title": "Boost Your Portfolio's Health With These 3 Big Drug Stocks", "image": "https://cdn.snapi.dev/images/v1/2/8/287-4.jpg", "site": "Zacks Investment Research", "text": "The large-cap pharma industry is doing well in 2019. Here are three stocks from the space that investors may consider betting on.", "url": "https://www.zacks.com/stock/news/428332/boost-your-portfolios-health-with-these-3-big-drug-stocks"}, {"symbol": "PFE", "publishedDate": "2019-06-12 07:35:40", "title": "4 Price Momentum Stocks Hedge Funds Love Could Be Big Summer Winners", "image": "https://cdn.snapi.dev/images/v1/8/h/8hed.jpg", "site": "24/7 Wall Street", "text": "We have noted that hedge fund performance over the past couple of years, especially by some of the bigger funds, has trailed the overall market performance.", "url": "https://247wallst.com/investing/2019/06/12/4-price-momentum-stocks-hedge-funds-love-could-be-big-summer-winners/"}, {"symbol": "PFE", "publishedDate": "2019-06-12 07:15:18", "title": "6 Most Shorted Dow Stocks", "image": "https://cdn.snapi.dev/images/v1/7/s/7sho-1.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://247wallst.com/investing/2019/06/12/6-most-shorted-dow-stocks-pfizer-still-on-top/"}, {"symbol": "PFE", "publishedDate": "2019-06-10 16:20:34", "title": "Five Health Care Stocks Gurus Are Buying", "image": "https://cdn.snapi.dev/images/v1/2/0/20heal.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.", "url": "https://www.gurufocus.com/news/891970/5-health-care-stocks-gurus-are-buying"}, {"symbol": "PFE", "publishedDate": "2019-06-10 10:33:00", "title": "These 3 Biotech Stocks Doubled in the First Half of 2019", "image": "https://cdn.snapi.dev/images/v1/e/t/etf24-23.jpg", "site": "The Motley Fool", "text": "Could the second half of the year be as much fun as the first?", "url": "https://www.fool.com/investing/2019/06/10/these-3-biotech-stocks-doubled-in-first-half-2019.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-07 07:45:00", "title": "Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far", "image": "https://cdn.snapi.dev/images/v1/u/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5178452fscientist-holding-a-test-tube.jpg", "site": "The Motley Fool", "text": "They might be this year's Bad News Bears, but I think these three stocks will be long-term winners.", "url": "https://www.fool.com/investing/2019/06/07/why-im-sticking-with-my-3-worst-performing-stocks.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-06 09:31:26", "title": "Why Is Array BioPharma (ARRY) Up 27.1% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/b/n/biotech8.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma (ARRY) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/425534/why-is-array-biopharma-arry-up-271-since-last-earnings-report"}, {"symbol": "PFE", "publishedDate": "2019-06-06 09:05:00", "title": "5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug", "image": "https://cdn.snapi.dev/images/v1/n/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5278612fhealthcare-provider-helping-a-patient-stand-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "America's largest pharmaceutical company had plenty of good reasons not to pursue a potential new Alzheimer's treatment.", "url": "https://www.fool.com/investing/2019/06/06/5-reasons-pfizer-sat-on-a-potential-new-alzheimers.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-06 08:50:45", "title": "3 Big Stock Charts for Thursday: Pfizer, Walmart and FleetCor Technologies", "image": "https://cdn.snapi.dev/images/v1/e/t/etf14-30.jpg", "site": "InvestorPlace", "text": "The stock charts of WMT, FLT and PFE are headed into the latter half of the week at inflection points. Here's what you can expect from each.", "url": "https://investorplace.com/2019/06/3-big-stock-charts-for-thursday-pfizer-walmart-and-fleetcor-technologies/"}, {"symbol": "PFE", "publishedDate": "2019-06-05 13:31:45", "title": "Pfizer denies report it hid possible Alzheimer\u2019s breakthrough", "image": "https://cdn.snapi.dev/images/v1/q/8/pfizer-alzheimers-reportjpgquality90stripall.jpg", "site": "New York Post", "text": "Pfizer is fighting back against a report that it hid the potential of a blockbuster drug to prevent Alzheimer\u2019s disease in order to avoid shelling out for a \u201ccostly clinical trial.\u201d Researchers at Pfizer in 2015 found that Enbrel, an anti-inflammatory drug used to treat rheumatioid arthritis, seemed to reduce the risk of Alzheimer\u2019s disease.", "url": "https://nypost.com/2019/06/05/pfizer-denies-report-it-hid-possible-alzheimers-breakthrough/"}, {"symbol": "PFE", "publishedDate": "2019-06-05 09:05:00", "title": "Pfizer to Launch Several Drugs Despite Generic Headwinds", "image": "https://cdn.snapi.dev/images/v1/s/z/drugs16.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) looks well positioned to launch several breakthrough innovative medicines in the next five years amid loss of exclusivity headwinds.", "url": "https://www.zacks.com/stock/news/424912/pfizer-to-launch-several-drugs-despite-generic-headwinds"}, {"symbol": "PFE", "publishedDate": "2019-06-05 07:06:00", "title": "The Four Most Oversold Dow Stocks", "image": "https://cdn.snapi.dev/images/v1/1/1/11over.jpg", "site": "Forbes", "text": "Many of the stocks in the Dow Industrial Average dropped sharply in May as fears over the deepening trade war made them less attractive to investors. In his regular monthly scan, Viper Report\u2019s Tom Aspray discusses the four most oversold Dow stocks.", "url": "https://www.forbes.com/sites/tomaspray/2019/06/05/the-four-most-oversold-dow-stocks/"}, {"symbol": "PFE", "publishedDate": "2019-06-04 15:18:11", "title": "The 10 Best Stocks for 2019 \u2014 So Far", "image": "https://cdn.snapi.dev/images/v1/b/u/bul23.jpg", "site": "InvestorPlace", "text": "Roku, Array Biopharma and Guardant Health are just some of the best stocks by returns for the first half of 2019. The post The 10 Best Stocks for 2019 \u2014 So Far appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/06/the-10-best-stocks-for-2019-so-far/"}, {"symbol": "PFE", "publishedDate": "2019-06-04 13:57:00", "title": "Top Research Reports for Pfizer, Coca-Cola & VMware", "image": "https://cdn.snapi.dev/images/v1/r/l/asset-management19.jpg", "site": "Zacks Investment Research", "text": "Top Research Reports for Pfizer, Coca-Cola & VMware", "url": "https://www.zacks.com/research-daily/424605/top-research-reports-for-pfizer-coca-cola-vmware"}, {"symbol": "PFE", "publishedDate": "2019-06-04 09:21:00", "title": "3 Cancer Stocks Given a Lift by Amgen", "image": "https://cdn.snapi.dev/images/v1/n/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5183412fbiotech-stocks-to-own.jpg", "site": "The Motley Fool", "text": "Success with an experimental new oncology treatment that scratches a 35-year itch is good news for more than one biotech stock.", "url": "https://www.fool.com/investing/2019/06/04/3-cancer-stocks-given-a-lift-by-amgen.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-03 16:05:11", "title": "6 High-Yield Stocks", "image": "https://cdn.snapi.dev/images/v1/e/t/etf14-29.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-in-One Screener, the following companies have high dividend yields but performed poorly over the last 12 months.", "url": "https://www.gurufocus.com/news/888731/6-highyield-stocks"}, {"symbol": "PFE", "publishedDate": "2019-06-03 08:42:00", "title": "'Dogs Of The Dow' Slump, Here's How To Trade Them Now", "image": "https://cdn.snapi.dev/images/v1/1/4/14dow.jpg", "site": "Forbes", "text": "The eight \u201cDogs of the Dow\u201d for 2019 have an aggregate year-to-date gain of 5.5% at the end of May, down from 12.2% at the end of April. Here's how to buy and sell them now.", "url": "https://www.forbes.com/sites/investor/2019/06/03/dogs-of-the-dow-slump-heres-how-to-trade-them-now/"}, {"symbol": "PFE", "publishedDate": "2019-05-30 12:59:00", "title": "Only five Dow stocks have gained in May as trade war drags on", "image": "https://cdn.snapi.dev/images/v1/1/0-2/103310522-gettyimages-479184028.jpg", "site": "CNBC", "text": "Just five Dow components were poised for May gains Thursday afternoon, a reflection of the effect the trade war is having on Wall Street.", "url": "https://www.cnbc.com/2019/05/30/only-five-dow-stocks-have-gained-in-may-as-trade-war-drags-on.html"}, {"symbol": "PFE", "publishedDate": "2019-05-30 10:34:00", "title": "2 Ultra-High-Growth Biotech Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech38-6.jpg", "site": "The Motley Fool", "text": "Amicus Therapeutics and Array BioPharma are two top growth stocks to consider buying now.", "url": "https://www.fool.com/investing/2019/05/30/2-ultra-high-growth-biotech-stocks-to-buy-now.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-30 09:31:52", "title": "Pfizer (PFE) Up 2.3% Since Last Earnings Report: Can It Continue?", "image": "https://cdn.snapi.dev/images/v1/i/b/pfi92.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/422183/pfizer-pfe-up-23-since-last-earnings-report-can-it-continue"}, {"symbol": "PFE", "publishedDate": "2019-05-29 22:07:38", "title": "Array's Positive Phase 3 Results Make The Case For Revenue Growth For BRAFTOVI And METKOVI", "image": "https://cdn.snapi.dev/images/v1/d/m/biotech27.jpg", "site": "Seeking Alpha", "text": "Array obtained positive results for its phase 3 BEACON CRC study using BRAFTOVI, METKOVI, and ERBITUX to treat patients with BRAF mutant metastatic colorectal cancer.", "url": "https://seekingalpha.com/article/4267182-arrays-positive-phase-3-results-make-case-revenue-growth-braftovi-metkovi?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-05-28 15:36:50", "title": "This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5270562fdrugs-pharmaceuticals-pill-box-pills-2018-05-10-12-39-51-utcjpgw700opresize.jpg", "site": "The Motley Fool", "text": "And the analyst really likes one in particular.", "url": "https://www.fool.com/investing/2019/05/28/this-just-in-goldman-sachs-picks-4-big-pharma-stoc.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-28 14:39:44", "title": "4 Drug and Health Stocks Pushing Higher \u00a0", "image": "https://cdn.snapi.dev/images/v1/b/i/biotechmsn-compressed.jpg", "site": "InvestorPlace", "text": "U.S. equities are mostly higher in post-holiday trading on Tuesday, as investors are looking for stocks to buy.", "url": "https://feedproxy.google.com/~r/InvestorPlace/~3/71FlC3SQO_c/"}, {"symbol": "PFE", "publishedDate": "2019-05-27 09:22:00", "title": "Pfizer's (PFE) Epilepsy Drug Lyrica Fails in Phase III Study", "image": "https://cdn.snapi.dev/images/v1/l/s/pf9-3.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) announces failure of a phase III study evaluating Lyrica in patients with primary generalized tonic-clonic seizures, a form of epilepsy.", "url": "https://www.zacks.com/stock/news/420063/pfizers-pfe-epilepsy-drug-lyrica-fails-in-phase-iii-study"}, {"symbol": "PFE", "publishedDate": "2019-05-24 16:20:20", "title": "Pfizer's Lyrica doesn't meet endpoint in epilepsy study", "image": "https://cdn.snapi.dev/images/v1/l/y/ly7dr.jpg", "site": "Market Watch", "text": "Pfizer Inc. said late Friday one of its drugs did not meet set goals for the treatment of epilepsy in a late stage clinical trial.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/gmEaZnwq7Fw/story.aspx"}, {"symbol": "PFE", "publishedDate": "2019-05-23 18:58:51", "title": "Pfizer Has Limited Downside", "image": "https://cdn.snapi.dev/images/v1/o/s/11-2.jpg", "site": "Seeking Alpha", "text": "10-year chart shows strong support for shares.", "url": "https://seekingalpha.com/article/4266229-pfizer-limited-downside?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-05-23 14:21:02", "title": "Pfizer or Johnson & Johnson? The viewers #AskHalftime", "image": "https://cdn.snapi.dev/images/v1/p/f/pfzj7.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Pfizer & J&J.", "url": "https://www.youtube.com/watch?v=RtaOeJqeP8c&t=36s"}, {"symbol": "PFE", "publishedDate": "2019-05-23 14:14:00", "title": "Mr. Wonderful's Top 10 Dividend Stocks", "image": "https://cdn.snapi.dev/images/v1/0/x/0x600-149.jpg", "site": "Forbes", "text": "Kevin O\u2019Leary is Chairman of O\u2019Shares Investments, but you probably know him as \u201cMr. Wonderful\u201d from Shark Tank, assertsBen Reynolds, editor ofSure Dividendand contributor toMoneyShow.comin a special report that analyzes some of the shark\u2019s top high quality, dividend paying ideas.", "url": "https://www.forbes.com/sites/moneyshow/2019/05/23/mr-wonderfuls-top-10-dividend-stocks/"}, {"symbol": "PFE", "publishedDate": "2019-05-23 08:54:00", "title": "Array BioPharma Inc. (ARRY) Shares March Higher, Can It Continue?", "image": "https://cdn.snapi.dev/images/v1/j/i/biotech6.jpg", "site": "Zacks Investment Research", "text": "As of late, it has definitely been a great time to be an investor in Array BioPharma Inc. (ARRY).", "url": "https://www.zacks.com/stock/news/418486/array-biopharma-inc-arry-shares-march-higher-can-it-continue"}, {"symbol": "PFE", "publishedDate": "2019-05-21 09:00:00", "title": "Better Buy: AbbVie vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/k/5/hcs2.jpg", "site": "The Motley Fool", "text": "AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger?", "url": "https://www.fool.com/investing/2019/05/21/better-buy-abbvie-vs-pfizer.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-20 12:04:42", "title": "Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock", "image": "https://cdn.snapi.dev/images/v1/p/f/pfemsn-300x165.jpg", "site": "InvestorPlace", "text": "Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.", "url": "https://feedproxy.google.com/~r/InvestorPlace/~3/30572ZveJNQ/"}, {"symbol": "PFE", "publishedDate": "2019-05-15 08:00:19", "title": "Pfizer Stock Is The Biggest Pharma \u2014 But Should You Buy It?", "image": "https://cdn.snapi.dev/images/v1/d/a/drugs11.jpg", "site": "Investors Business Daily", "text": "Pfizer stock has fallen 7.1% this year, behind pharma stocks. Recent news has been upbeat with a drug approval and earnings beat.", "url": "https://feedproxy.google.com/~r/InternetTechnologyRss/~3/ciWE76f27MY/"}, {"symbol": "PFE", "publishedDate": "2019-05-14 07:39:05", "title": "Shark Tank's Kevin O'Leary: Keep your stock picks boring during trade turmoil", "image": "https://cdn.snapi.dev/images/v1/m/q-4/shark-tanks-kevin-oleary-keep-your-stock-picks-boring-during-trade-turmoil.jpg", "site": "CNBC Television", "text": "Guest Host Kevin O'Leary of Shark Tank joins \"Squawk Box\" to give his top stock picks amid the market sell-off and what he thinks investors should do about Boeing.", "url": "https://www.youtube.com/watch?v=7DoVpIJT2qQ"}, {"symbol": "PFE", "publishedDate": "2019-05-12 11:00:00", "title": "Top vaccine makers Merck and Pfizer target China and older adults next", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi22.jpg", "site": "CNBC", "text": "The four companies that now dominate global vaccine sales are Merck, Pfizer, Sanofi Pasteur and GlaxoSmithKline.", "url": "https://www.cnbc.com/2019/05/10/merck-pfizer-sanofi-pasteur-and-glaxosmithkline-make-billions-from-shingrix-and-gardasil-vaccines.html"}, {"symbol": "PFE", "publishedDate": "2019-05-10 09:00:07", "title": "All You Need to Know About Array BioPharma (ARRY) Rating Upgrade to Buy", "image": "https://cdn.snapi.dev/images/v1/r/e/biotech3.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma (ARRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "url": "https://www.zacks.com/stock/news/412542/all-you-need-to-know-about-array-biopharma-arry-rating-upgrade-to-buy"}, {"symbol": "PFE", "publishedDate": "2019-05-09 14:10:45", "title": "2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure", "image": "https://cdn.snapi.dev/images/v1/6/e/6el.jpg", "site": "24/7 Wall Street", "text": "Thursday market saw two very successful IPOs in the emerging biotech sector.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/viMU8PpZeNU/"}, {"symbol": "PFE", "publishedDate": "2019-05-08 11:17:51", "title": "Pfizer Buys Rare Disease Biotech Therachon For $340M", "image": "https://cdn.snapi.dev/images/v1/s/9/syringe-1884758-1920-7-4.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE) said Wednesday that it reached a definitive agreement to acquire all the shares of Therachon Holding AG, a privately held clinical-stage biotech\u00a0focused on rare diseases.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/WV6qRuusYTc/pfizer-buys-rare-disease-biotech-therachon-for-340m"}, {"symbol": "PFE", "publishedDate": "2019-05-08 09:56:00", "title": "Array BioPharma (ARRY) Q3 Earnings and Sales Beat Estimates", "image": "https://cdn.snapi.dev/images/v1/y/c/biotech17.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma's (ARRY) top and bottom lines beat estimates in the third quarter of fiscal 2019. Momentum in uptake of Braftovi-Mektovi combination therapy continues.", "url": "https://www.zacks.com/stock/news/411124/array-biopharma-arry-q3-earnings-and-sales-beat-estimates"}, {"symbol": "PFE", "publishedDate": "2019-05-07 20:21:00", "title": "Can Pfizer Leap Over the Competition With This Potential Blockbuster?", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-25-193063-ojpg.jpg", "site": "The Motley Fool", "text": "It's been nearly seven years since the FDA refused to approve tafamidis's first new drug application, and the field is a lot more crowded now.", "url": "https://www.fool.com/investing/2019/05/07/can-pfizer-leap-over-competition-with-tafamidis.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-07 16:48:05", "title": "Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/n/s/transcript6jpg.jpg", "site": "Seeking Alpha", "text": "Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4261149-array-biopharma-inc-arry-ceo-ron-squarer-q3-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "PFE", "publishedDate": "2019-05-07 09:15:03", "title": "Array BioPharma (ARRY) Reports Q3 Loss, Tops Revenue Estimates", "image": "https://cdn.snapi.dev/images/v1/o/z/biotech2jpg.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma (ARRY) delivered earnings and revenue surprises of 19.05% and 25.59%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/410143/array-biopharma-arry-reports-q3-loss-tops-revenue-estimates"}, {"symbol": "PFE", "publishedDate": "2019-05-06 13:16:03", "title": "How Dow Jones' Pfizer Could Take On New Drugs From 2 Biotech Stocks", "image": "https://cdn.snapi.dev/images/v1/e/l/pfz.jpg", "site": "Investors Business Daily", "text": "Dow Jones component Pfizer gained approval Monday for a drug that treats a rare heart disease\u00a0\u2014 potentially rivaling new drugs from Alnylam Pharmaceuticals and Ionis Pharmaceuticals.", "url": "https://feedproxy.google.com/~r/BusinessRss/~3/dVL5agWqXzw/"}, {"symbol": "PFE", "publishedDate": "2019-05-05 07:30:00", "title": "5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term", "image": "https://cdn.snapi.dev/images/v1/a/h/pd2.jpg", "site": "The Motley Fool", "text": "A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.", "url": "https://www.fool.com/investing/2019/05/05/5-reasons-why-pfizer-is-a-great-stock-to-buy-and-h.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-03 14:16:00", "title": "Pfizer Beats In Q1 But Lyrica Headwinds Will Likely Weigh On Near Term Growth", "image": "https://cdn.snapi.dev/images/v1/l/o/pf9.jpg", "site": "Forbes", "text": "Pfizer recently reported its Q1 2019 results, which were above our estimates. This note details the company\u2019s Q1 performance, and Trefis\u2019 forecast for the full year 2019.", "url": "https://www.forbes.com/sites/greatspeculations/2019/05/03/pfizer-beats-in-q1-but-lyrica-headwinds-will-likely-weigh-on-near-term-growth/"}, {"symbol": "PFE", "publishedDate": "2019-05-02 14:18:22", "title": "Pfizer Stock Rebounds Under Cloud of Negative Charts", "image": "https://cdn.snapi.dev/images/v1/2/b/drugs48jpg.jpg", "site": "Investopedia", "text": "Pfizer reported better-then-expected earnings on April 30, but the stock is under a \"death cross\" and a negative weekly chart.", "url": "https://www.investopedia.com/pfizer-stock-rebounds-under-cloud-of-negative-charts-4686156"}, {"symbol": "PFE", "publishedDate": "2019-05-01 18:26:42", "title": "The top 2 health care names to play for a catch-up: Technician", "image": "https://cdn.snapi.dev/images/v1/h/e/he2l3.jpg", "site": "CNBC Television", "text": "Mark Newton, Newton Advisors, on playing catch-up with health care stocks.", "url": "https://www.youtube.com/watch?v=20YklDG_jUo"}, {"symbol": "PFE", "publishedDate": "2019-05-01 14:54:36", "title": "How Viagra Made Pfizer Billions Despite Generics", "image": "https://cdn.snapi.dev/images/v1/a/q/how-viagra-made-pfizer-billions-despite-generics.jpg", "site": "CNBC", "text": "Pfizer still holds the lead in the erectile dysfunction market even as Viagra sales falter.", "url": "https://www.youtube.com/watch?v=8f8ldl8-3AQ"}, {"symbol": "PFE", "publishedDate": "2019-04-30 14:11:21", "title": "Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/j/v/transcript46.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4258082-pfizer-inc-pfe-ceo-albert-bourla-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "PFE", "publishedDate": "2019-04-30 13:28:47", "title": "Pfizer CEO: Drug prices will not be a growth driver", "image": "https://cdn.snapi.dev/images/v1/m/q-3/pfizer-ceo-drug-prices-will-not-be-a-growth-driver.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on Pfizer's CEO claiming drug volume will drive growth for the company, not drug prices.", "url": "https://www.youtube.com/watch?v=An2kHegfIb8"}, {"symbol": "PFE", "publishedDate": "2019-04-30 13:00:00", "title": "What You Need to Know About Pfizer's Q1 Earnings Beat", "image": "https://cdn.snapi.dev/images/v1/a/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5217742fpfizer-earnings-04302019.jpg", "site": "The Motley Fool", "text": "The big drugmaker exceeded expectations in Q1 on both the top and bottom lines.", "url": "https://www.fool.com/investing/2019/04/30/what-you-need-to-know-about-pfizers-q1-earnings-be.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-30 12:15:31", "title": "Why Pfizer Shareholders Are Smiling After Earnings", "image": "https://cdn.snapi.dev/images/v1/p/f/pf9-4.jpg", "site": "24/7 Wall Street", "text": "When Pfizer Inc. reported first-quarter 2019 results before markets opened Tuesday, the drugmaker posted adjusted diluted earnings per share (EPS) of $0.85 on revenues of $13.12 billion.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/mvJQvAx9tVk/"}, {"symbol": "PFE", "publishedDate": "2019-04-30 09:33:00", "title": "Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi92.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) beat estimates for first-quarter earnings and sales and raised the mid-point of its earnings expectations for 2019 by a penny and confirmed its previous outlook for full-year sales.", "url": "https://www.zacks.com/stock/news/405867/pfizer-pfe-beats-on-q1-earnings-sales-raises-eps-view"}, {"symbol": "PFE", "publishedDate": "2019-04-30 07:35:42", "title": "Pfizer stock up 1.7% after earnings and revenue beat", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer5-2.jpg", "site": "Market Watch", "text": "Shares of Pfizer rose 1.7% in premarket trade Tuesday after the company reported first-quarter earnings and revenue that beat expectations, while raising its full-year guidance.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/ubFp54YYhLU/story.aspx"}, {"symbol": "PFE", "publishedDate": "2019-04-30 07:27:10", "title": "Here's a breakdown of Big Pharma earnings from Merck, Pfizer, Eli Lilly", "image": "https://cdn.snapi.dev/images/v1/m/q-3/heres-a-breakdown-of-big-pharma-earnings-from-merck-pfizer-eli-lilly.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell joins \"Squawk Box\" to discuss how earnings results from Pfizer, Merck and Eli Lilly compare.", "url": "https://www.youtube.com/watch?v=Fb9sFhR7yXE"}, {"symbol": "PFE", "publishedDate": "2019-04-30 07:20:00", "title": "Three major pharmaceutical companies just reported earnings \u2014 here\u2019s how they did", "image": "https://cdn.snapi.dev/images/v1/m/j/mjb6-2.jpg", "site": "CNBC", "text": "Shares of Pfizer and Merck rose after reporting financial results that beat expectations.", "url": "https://www.cnbc.com/2019/04/30/3-major-pharma-companies-just-reported-earning-heres-how-they-did.html"}, {"symbol": "PFE", "publishedDate": "2019-04-30 07:13:33", "title": "Pfizer, Merck both post earnings beats", "image": "https://cdn.snapi.dev/images/v1/m/q-3/pfizer-merck-both-post-earnings-beats.jpg", "site": "CNBC Television", "text": "\"Squawk Box\" reports on Pfizer's and Merck's earnings results and 2019 outlook.", "url": "https://www.youtube.com/watch?v=zwMShmxlZts"}, {"symbol": "PFE", "publishedDate": "2019-04-30 06:00:00", "title": "Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks", "image": "https://cdn.snapi.dev/images/v1/4/h/4hc.jpg", "site": "The Motley Fool", "text": "There's a clear and present danger to many healthcare stocks that's more serious than anything ever before.", "url": "https://www.fool.com/investing/2019/04/30/why-this-could-be-the-most-dangerous-time-ever-for.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-28 09:00:00", "title": "AbbVie vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/i/c/391.jpg", "site": "The Motley Fool", "text": "Which big pharma stock is more likely to be the bigger winner over the long run?", "url": "https://www.fool.com/investing/2019/04/28/better-buy-pfizer-vs-abbvie.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-26 06:45:37", "title": "Pfizer & Apple: The Most Shorted Dow Stocks in April", "image": "https://cdn.snapi.dev/images/v1/p/a/pa22.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or at least for their share prices to fall handily.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/cGKNLHWlzrg/"}, {"symbol": "PFE", "publishedDate": "2019-04-24 21:06:55", "title": "Merck Maintains Status In Front-Line Cancer Space", "image": "https://cdn.snapi.dev/images/v1/f/d/fda3.jpg", "site": "Seeking Alpha", "text": "Merck announced FDA approval for Keytruda given in combination with Pfizer's Inlyta to treat front-line advanced kidney cancer patients.", "url": "https://seekingalpha.com/article/4256488-merck-maintains-status-front-line-cancer-space?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-04-24 16:29:00", "title": "Pfizer to Report Q1 Earnings: Will It Beat Estimates?", "image": "https://cdn.snapi.dev/images/v1/r/d/pfi88.jpg", "site": "Zacks Investment Research", "text": "While Pfizer's (PFE) key drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericization of key drugs and weak sales in the EH segment will hurt.", "url": "https://www.zacks.com/stock/news/398971/pfizer-pfe-to-report-q1-earnings-will-it-beat-estimates"}, {"symbol": "PFE", "publishedDate": "2019-04-23 15:54:00", "title": "Kidney-Cancer Market: Good for Patients, Hard for Investors", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5201622fdoctor-patient-2.jpg", "site": "The Motley Fool", "text": "Drugmakers battle for patients.", "url": "https://www.fool.com/investing/2019/04/23/kidney-cancer-market-good-for-patients-hard-for-in.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-23 10:32:35", "title": "Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release", "image": "https://cdn.snapi.dev/images/v1/v/3/pf9.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/391530/pfizer-pfe-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release"}, {"symbol": "PFE", "publishedDate": "2019-04-22 17:34:00", "title": "Exact Sciences Is Near an All-Time High: Here's Why It Could Go Even Higher", "image": "https://cdn.snapi.dev/images/v1/e/x/exv2.jpg", "site": "The Motley Fool", "text": "Here's why Cologuard's popularity will continue to climb for a long time.", "url": "https://www.fool.com/investing/2019/04/22/exact-sciences-is-near-an-all-time-high-heres-why.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-22 10:24:22", "title": "Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns", "image": "https://cdn.snapi.dev/images/v1/t/j/syringe-1884758-1920-7-2.jpg", "site": "Benzinga", "text": "Eli Lilly And Co (NYSE: LLY)\u00a0faced a setback following the  release of top-line results from a late-stage study of its pain medication candidate.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/2Mn0g6Uelic/eli-lilly-pfizers-non-opioid-painkiller-faces-safety-efficacy-concerns"}, {"symbol": "PFE", "publishedDate": "2019-04-19 14:12:00", "title": "5 Top Pharmaceutical Stocks to Buy in 2019", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5178452fscientist-holding-a-test-tube.jpg", "site": "The Motley Fool", "text": "Some are really big, while others are relatively small. But all these pharmaceutical stocks look like promising picks for 2019.", "url": "https://www.fool.com/investing/2019/04/19/5-top-pharmaceutical-stocks-to-buy-in-2019.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-18 18:37:16", "title": "Pfizer, Lilly shares decline as osteoarthritis drug misses goals in study", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech33-2.jpg", "site": "Market Watch", "text": "Shares of drug makers Pfizer Inc. and Eli Lilly & Co. declined in the extended session Thursday after the companies said a clinical study of an osteoarthritis drug didn't meet certain goals.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/kLsbz4SWgaE/story.aspx"}, {"symbol": "PFE", "publishedDate": "2019-04-14 07:00:00", "title": "The 3 Greatest Risks Pfizer Faces", "image": "https://cdn.snapi.dev/images/v1/p/d/pd2.jpg", "site": "The Motley Fool", "text": "Here's what could get in the way of the big pharma company's future success.", "url": "https://www.fool.com/investing/2019/04/14/the-3-greatest-risks-pfizer-faces.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-11 03:05:59", "title": "Pfizer: A Better Prospect", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-25-193063-o-2.jpg", "site": "Seeking Alpha", "text": "Historical and projected rates of return for Johnson & Johnson are compared to similar data for Pfizer - with Pfizer, perhaps surprisingly, coming out a clear winner.", "url": "https://seekingalpha.com/article/4253889-johnson-and-johnson-solid-stable-returns-pfizer-better-prospect?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-04-10 17:45:21", "title": "Pfizer Stock Sinks As Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi9.jpg", "site": "Zacks Investment Research", "text": "Pfizer closed the most recent trading day at $42.73, moving -0.26% from the previous trading session.", "url": "https://www.zacks.com/stock/news/378063/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2019-04-10 10:19:02", "title": "Pfizer: Solid, Stable Returns", "image": "https://cdn.snapi.dev/images/v1/1/1/11-2.jpg", "site": "Seeking Alpha", "text": "Supported by large share repurchases, Pfizer share price has shown steady growth, from ~$25 in 2012 to the current level.", "url": "https://seekingalpha.com/article/4253754-pfizer-solid-stable-returns?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-04-10 07:30:39", "title": "The 5 Most Shorted Dow Stocks: Pfizer", "image": "https://cdn.snapi.dev/images/v1/p/f/pf9-3.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/vPJVvbrTkfI/"}, {"symbol": "PFE", "publishedDate": "2019-04-09 08:20:49", "title": "Brand-name drugs cost 18 times more than generics: AARP", "image": "https://cdn.snapi.dev/images/v1/m/q-2/brand-name-drugs-cost-18-times-more-than-generics-aarp.jpg", "site": "Fox Business", "text": "AARP Health Services Research Director Leigh Purvis discusses why drug prices are so high.", "url": "https://www.youtube.com/watch?v=5QOl-0NeTBM"}, {"symbol": "PFE", "publishedDate": "2019-04-05 21:26:00", "title": "Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men", "image": "https://cdn.snapi.dev/images/v1/5/4/547-3.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) blockbuster breast cancer medicine gets FDA approval to treat men. The approval for the expanded indication is based predominately on real-world data.", "url": "https://www.zacks.com/stock/news/371728/pfizers-ibrance-gets-fda-approval-for-breast-cancer-in-men"}, {"symbol": "PFE", "publishedDate": "2019-04-02 10:54:24", "title": "Gene-Editing Biotechs Pop After Pfizer Partner Scores In Hemophilia A", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech39.jpg", "site": "Investors Business Daily", "text": "Sangamo Therapeutics popped to a five-month high Tuesday after its gene-editing therapy showed promise as a hemophilia A treatment. Sangamo stock jumped by double digits in high volume.", "url": "https://feedproxy.google.com/~r/BusinessRss/~3/tAUmjaSwIZ0/"}, {"symbol": "PFE", "publishedDate": "2019-04-01 13:03:24", "title": "Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts", "image": "https://cdn.snapi.dev/images/v1/p/f/pf9.jpg", "site": "Benzinga", "text": "Large-cap pharma stocks have seen a mixed performance in year to date, and among this group, Pfizer Inc.  is poised to benefit from some key second-half catalysts, according to an analyst at Bank of America Merrill Lynch.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/IXoj1Kd4e9w/bank-of-america-hikes-pfizer-price-target-estimates-cit"}]